» Authors » Yvo B W E M Roos

Yvo B W E M Roos

Explore the profile of Yvo B W E M Roos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 187
Citations 10186
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavalcante F, Treurniet K, Kappelhof M, Kaesmacher J, Lingsma H, Saver J, et al.
Stroke . 2025 Jan; 56(2):543-552. PMID: 39744847
Noninferiority trials aim to prove that the efficacy, defined in terms of a key clinical outcome, of a new treatment is not meaningfully worse than that of an established active...
2.
Nio S, Rinkel L, van Schuppen J, Spijkerboer A, Beemsterboer C, Guglielmi V, et al.
Stroke . 2024 Dec; 56(2):420-426. PMID: 39704069
Background: Cardiac computed tomography (CT) is increasingly used to search for cardioembolic sources of acute ischemic stroke (AIS). We assessed the association between high-risk cardioembolic sources on cardiac CT and...
3.
Verbruggen L, Kok J, Kremer L, Janssens G, Nederkoorn P, Penson A, et al.
Int J Cancer . 2024 Dec; PMID: 39686528
Cerebrovascular events (CVEs) are serious late adverse events among childhood cancer survivors. We estimated the incidence and risk factors of symptomatic CVEs and described the clinical characteristics among childhood cancer...
4.
Hansen D, den Hartog S, van Leeuwen N, Boiten J, Dinkelaar W, van Doormaal P, et al.
JAMA Neurol . 2024 Dec; 82(2):160-167. PMID: 39680396
Importance: Efficient care processes are crucial to minimize treatment delays and improve outcome after endovascular thrombectomy (EVT) in patients with ischemic stroke. A potential means to improve care processes is...
5.
Ceulemans A, Barakzie A, Spronk H, de Maat M, van Beusekom H, Taha A, et al.
Thromb Res . 2024 Nov; 245:109212. PMID: 39571223
Background: The MR CLEAN NO-IV trial showed neither superiority nor noninferiority of endovascular treatment (EVT) alone compared to intravenous thrombolysis (IVT; Alteplase) before EVT in acute ischemic stroke (AIS) patients...
6.
Barakzie A, Jansen A, Cavalcante F, Nagy M, Dippel D, van der Lugt A, et al.
J Thromb Haemost . 2024 Oct; 23(1):235-247. PMID: 39442626
Background: Intravenous thrombolysis (IVT) using recombinant tissue plasminogen activator prior to endovascular thrombectomy treatment (EVT) failed to improve treatment effect in acute ischemic stroke (AIS) patients compared with EVT alone....
7.
Nio S, Rinkel L, Cramer O, Ozata Z, Beemsterboer C, Guglielmi V, et al.
J Am Heart Assoc . 2024 Aug; 13(17):e034106. PMID: 39190561
Background: Left atrial appendage (LAA) slow-flow may increase the risk of ischemic stroke. We studied LAA attenuation on cardiac computed tomography in patients with acute ischemic stroke. Methods And Results:...
8.
Nguyen C, Lahr M, van der Zee D, Rinkel L, van Voorst H, Pinckaers F, et al.
Stroke . 2024 Aug; 55(10):2482-2491. PMID: 39129622
Background: The benefit of intravenous thrombolysis with alteplase before endovascular thrombectomy (EVT) for acute ischemic stroke due to large vessel occlusion remains debated. In this study, we analyzed the cost-effectiveness...
9.
Tanaka K, Brown S, Goyal M, Menon B, Campbell B, Mitchell P, et al.
Stroke . 2024 Jul; 55(8):1982-1990. PMID: 39038101
Background: Clinicians need simple and highly predictive prognostic scores to assist practical decision-making. We aimed to develop a simple outcome prediction score applied 24 hours after anterior circulation acute ischemic...
10.
Huijberts I, Pinckaers F, Olthuis S, van Kuijk S, Postma A, Boogaarts H, et al.
Lancet Neurol . 2024 Jun; 23(9):893-900. PMID: 38909624
Background: The MR CLEAN-LATE trial provided evidence for the safety and efficacy of endovascular treatment for acute ischaemic stroke within the late window (after 6-24 h) in patients who were...